These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36822100)

  • 1. Retraction notice to "Down-regulated microRNA-195-5p and up-regulated CXCR4 attenuates the heart function injury of heart failure mice via inactivating JAK/STAT pathway" [Int. Immunopharmacol. 82 (2020) 106225].
    Shen Y; Zhang W; Lee L; Hong M; Lee M; Chou G; Yu L; Sui Y; Chou B
    Int Immunopharmacol; 2023 Apr; 117():109868. PubMed ID: 36822100
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED: Down-regulated microRNA-195-5p and up-regulated CXCR4 attenuates the heart function injury of heart failure mice via inactivating JAK/STAT pathway.
    Shen Y; Zhang W; Lee L; Hong M; Lee M; Chou G; Yu L; Sui Y; Chou B
    Int Immunopharmacol; 2020 Mar; 82():106225. PubMed ID: 32155465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice" [Int. Immunopharmacol. 93 (2021) 107389].
    Wu Z; Cheng S; Wang S; Li W; Liu J
    Int Immunopharmacol; 2023 Apr; 117():109863. PubMed ID: 36822088
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1a pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2023 Apr; 117():109870. PubMed ID: 36822086
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2" [Int. Immunopharmacol. 78 (2020) 105946].
    Jin Z; Ren J; Qi S
    Int Immunopharmacol; 2023 Apr; 117():109943. PubMed ID: 36914435
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "Exosomal microRNA-16-5p from adipose mesenchymal stem cells promotes TLR4-mediated M2 macrophage polarization in septic lung injury" [Int. Immunopharmacol. 98 (2021) 107835].
    Tian J; Cui X; Sun J; Zhang J
    Int Immunopharmacol; 2022 Oct; 111():109078. PubMed ID: 35952514
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Downregulation of microRNA-21-5p from macrophages-derived exosomes represses ventricular remodeling after myocardial infarction via inhibiting tissue inhibitors of metalloproteinase 3" [Int. Immunopharmacol. 96 (2021) 107611].
    Dong J; Zhu W; Wan D
    Int Immunopharmacol; 2023 Apr; 117():109862. PubMed ID: 36822081
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis" [Int. Immunopharmacol. 78 (2020) 105985].
    Zheng J; Zhu L; In II; Chen Y; Jia N; Zhu W
    Int Immunopharmacol; 2023 Mar; 116():109873. PubMed ID: 36858851
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Upregulated microRNA-381-5p strengthens the effect of dexmedetomidinepreconditioning to protect against myocardial ischemia-reperfusion injuryin mouse models by inhibiting CHI3L1" [Int. Immunopharmacol. 92 (2021) 107326].
    Deng Y; Cai L; Wang F; Huang J; Wang H; Li L; Lv H
    Int Immunopharmacol; 2023 Apr; 117():109864. PubMed ID: 36822095
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "Inhibition of interleukin-1β plays a protective role in Alzheimer's disease by promoting microRNA-9-5p and downregulating targeting protein for xenopus kinesin-like protein 2" [Int. Immunopharmacol. 97 (2021) 107578].
    Zhang YY; Dong LX; Bao HL; Liu Y; An FM; Zhang GW
    Int Immunopharmacol; 2023 Apr; 117():109856. PubMed ID: 36822082
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "MicroRNA-375-3p in endothelial progenitor cells-derived extracellular vesicles relieves myocardial injury in septic rats via BRD4-mediated PI3K/AKT signaling pathway" [Int. Immunopharmacol. 96 (2021) 107740].
    Hong X; Wang J; Li S; Zhao Z; Feng Z
    Int Immunopharmacol; 2023 Apr; 117():109857. PubMed ID: 36822097
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "LncRNA NEAT1 inhibition upregulates miR-16-5p to restrain the progression of sepsis-induced lung injury via suppressing BRD4 in amouse model" [Int. Immunopharmacol. 97 (2021) 107691].
    Yin J; Han B; Shen Y
    Int Immunopharmacol; 2023 Apr; 117():109855. PubMed ID: 36822093
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway" [Int. Immunopharmacol. 50 (2017) 283-290].
    Zhang HJ; Wei QF; Wang SJ; Zhang HJ; Zhang XY; Geng Q; Cui YH; Wang XH
    Int Immunopharmacol; 2021 Jun; 95():107500. PubMed ID: 33674214
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Protective role of microRNA-27a upregulation and HSP90 silencing against cerebral ischemia-reperfusion injury in rats by activating PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 86 (2020) 106635].
    Zhang E; Chen Q; Wang J; Li D; Wan Z; Ju X
    Int Immunopharmacol; 2021 Oct; 99():108032. PubMed ID: 34348862
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis" [Int. Immunopharmacol. 67 (2019) 441-448].
    Liu M; Zhang J; Liu W; Wang W
    Int Immunopharmacol; 2021 Jun; 95():107711. PubMed ID: 33933373
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "The protective role of microRNA-133b in restricting hippocampal neurons apoptosis and inflammatory injury in rats with depression by suppressing CTGF" [Int. Immunopharmacol. 78 (2020) 106076].
    Pei G; Xu L; Huang W; Yin J
    Int Immunopharmacol; 2023 Apr; 117():109872. PubMed ID: 36822080
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Long non-coding RNA Mirt2 prevents TNF-α-triggered inflammation via the repression of microRNA-101" [Int. Immunopharmacol. 76 (2019) 105878].
    Han Y; Kang C; Kang M; Quan W; Gao H; Zhong Z
    Int Immunopharmacol; 2021 Oct; 99():108030. PubMed ID: 34353735
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Bone marrow mesenchymal stem cells-derived exosomal microRNA-185represses ventricular remolding of mice with myocardial infarction byinhibiting SOCS2" [Int. Immunopharmacol. 80 (2020) 106156].
    Li Y; Zhou J; Zhang O; Wu X; Guan X; Xue Y; Li S; Zhuang X; Zhou B; Miao G; Zhang L
    Int Immunopharmacol; 2023 Apr; 117():109871. PubMed ID: 36822089
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "MicroRNA-204-GSDMD interaction regulates pyroptosis of fibroblast-like synoviocytes in ankylosing spondylitis" [Int. Immunopharmacol. 91 (2020) 107227].
    Gu G; Huo Y; Xu G; Li L; Yu J; Sheng L; Yin Z
    Int Immunopharmacol; 2023 Apr; 117():109866. PubMed ID: 36822091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.